Uniject As A Delivery System For The Once-a-month Injectable Contraceptive Cyclofem In Brazil.

dc.creatorBahamondes, L
dc.creatorMarchi, N M
dc.creatorde Lourdes Cristofoletti, M
dc.creatorNakagava, H M
dc.creatorPellini, E
dc.creatorAraujo, F
dc.creatorRubin, J
dc.date1996-Feb
dc.date2015-11-27T12:18:46Z
dc.date2015-11-27T12:18:46Z
dc.date.accessioned2018-03-29T00:51:52Z
dc.date.available2018-03-29T00:51:52Z
dc.identifierContraception. v. 53, n. 2, p. 115-9, 1996-Feb.
dc.identifier0010-7824
dc.identifier
dc.identifierhttp://www.ncbi.nlm.nih.gov/pubmed/8838489
dc.identifierhttp://repositorio.unicamp.br/jspui/handle/REPOSIP/193933
dc.identifier8838489
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/1294166
dc.descriptionThis study assessed the administration of Cyclofem using prefilled Uniject devices. A total of 480 injections were administered divided equally between standard syringes and Uniject. The majority of women (82%) reported that they felt anxious prior to receiving the injection with Uniject. After injection, more than 80% expressed no anxiety about the appearance of Uniject or about the technique of injection. A total of 96.3% of the participants reported slight to no pain with Uniject. In comparison to the standard syringe, 5.6% expressed having had more pain with Uniject. Ninety percent of the service providers reported that Uniject was easy to activate and inject and that it was reassuring for users to know that the syringe and needle had never been used previously. Only two service providers demonstrated difficulties in activating the device. No accidental punctures occurred during the manipulation, and incomplete emptying of the Uniject was not observed. In conclusion, Uniject is a good device for the administration of the injectable contraceptive Cyclofem. It is likely to be appropriate for the delivery of other injectable contraceptives after the necessary stability tests have been performed.
dc.description53
dc.description115-9
dc.languageeng
dc.relationContraception
dc.relationContraception
dc.rightsfechado
dc.rights
dc.sourcePubMed
dc.subjectAnxiety
dc.subjectBrazil
dc.subjectContraceptive Agents, Female
dc.subjectContraceptives, Oral, Combined
dc.subjectEstradiol
dc.subjectFemale
dc.subjectHumans
dc.subjectInjections
dc.subjectMedroxyprogesterone Acetate
dc.subjectPain
dc.subjectAmericas
dc.subjectBehavior
dc.subjectBiology
dc.subjectBrazil
dc.subjectContraception
dc.subjectContraceptive Agents
dc.subjectContraceptive Agents, Female
dc.subjectContraceptive Agents, Progestin
dc.subjectContraceptive Methods
dc.subjectDeveloping Countries
dc.subjectEndocrine System
dc.subjectEquipment And Supplies
dc.subjectEstradiol
dc.subjectEstrogens
dc.subjectFamily Planning
dc.subjectHormones
dc.subjectInjectables
dc.subjectLatin America
dc.subjectMedroxyprogesterone Acetate
dc.subjectPerception
dc.subjectPhysiology
dc.subjectPsychological Factors
dc.subjectResearch Report
dc.subjectSouth America
dc.subjectSyringe
dc.titleUniject As A Delivery System For The Once-a-month Injectable Contraceptive Cyclofem In Brazil.
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución